I-Mab (IMAB)
NASDAQ: IMAB · Real-Time Price · USD
0.930
-0.051 (-5.17%)
Nov 21, 2024, 1:09 PM EST - Market open
I-Mab Market Cap
I-Mab has a market cap or net worth of $75.69 million as of November 21, 2024. Its market cap has decreased by -43.35% in one year.
Market Cap
75.69M
Enterprise Value
-100.80M
1-Year Change
-43.35%
Ranking
Category
Stock Price
$0.93
Market Cap Chart
Since January 17, 2020, I-Mab's market cap has decreased from $138.05M to $75.69M, a decrease of -45.17%. That is a compound annual growth rate of -11.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 79.81M | -49.39% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | 3.32B | 2,307.78% |
| Jan 17, 2020 | 138.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clearside Biomedical | 79.64M |
| MDxHealth | 79.44M |
| Chimerix | 79.14M |
| Renovaro | 78.57M |
| P3 Health Partners | 77.73M |
| Quince Therapeutics | 77.00M |
| ESSA Pharma | 76.76M |
| Oncolytics Biotech | 76.26M |